This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Davidovich, I. A. Articles by Roninson, I. B. Search for Related Content PubMed PubMed Citation Articles by Davidovich, I. A. Articles by Roninson, I. B.

Pleiotropic Resistance to DNA-interactive Drugs Is Associated with Increased Expression of Genes Involved in DNA Replication, Repair, and Stress Response¹

Department of Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois 60607-7170

A combination of four genetic suppressor elements (GSEs), two of which are derived from putative transcriptional regulators, was previously found to increase resistance to drugs inhibiting DNA replication in HT1080 fibrosarcoma cells. In the present study, two GSE-transduced cell lines, isolated with and without cytotoxic selection, were found to be resistant to a diverse group of DNA-interactive agents, including aphidicolin, hydroxyurea, cytarabine, etoposide, doxorubicin, and mafosfamide. Changes in gene expression associated with GSE-induced drug resistance were analyzed by cDNA array hybridization and reverse transcription-PCR. Twenty genes were found to be up-regulated in both of the resistant cell lines. These include genes involved in DNA replication and repair (e.g., PCNA, XRCC1, B-MYB, and GADD45), transcriptional regulators associated with stress response, and cell cycle checkpoint control (e.g., YB-1, DBPA, and ATF4), and genes for signal transduction proteins (e.g., protein tyrosine phosphatase 1B and regulatory subunits and ß of cAMP-dependent protein kinase). The observed changes in gene expression may play a role in pleiotropic resistance to different classes of DNA-targeting drugs.

This article has been cited by other articles:

				K. Mantwill, N. Kohler-Vargas, A. Bernshausen, A. Bieler, H. Lage, A. Kaszubiak, P. Surowiak, T. Dravits, U. Treiber, R. Hartung, et al. Inhibition of the Multidrug-Resistant Phenotype by Targeting YB-1 with a Conditionally Oncolytic Adenovirus: Implications for Combinatorial Treatment Regimen with Chemotherapeutic Agents. Cancer Res., July 15, 2006; 66(14): 7195 - 7202. [Abstract] [Full Text] [PDF]

				M. A. A. Koike Folgueira, D. M. Carraro, H. Brentani, D. F. da Costa Patrao, E. M. Barbosa, M. M. Netto, J. R. F. Caldeira, M. L. H. Katayama, F. A. Soares, C. T. Oliveira, et al. Gene Expression Profile Associated with Response to Doxorubicin-Based Therapy in Breast Cancer Clin. Cancer Res., October 15, 2005; 11(20): 7434 - 7443. [Abstract] [Full Text] [PDF]

				A. En-Nia, E. Yilmaz, U. Klinge, D. H. Lovett, I. Stefanidis, and P. R. Mertens Transcription Factor YB-1 Mediates DNA Polymerase {alpha} Gene Expression J. Biol. Chem., March 4, 2005; 280(9): 7702 - 7711. [Abstract] [Full Text] [PDF]

				M. Kuwano, Y. Oda, H. Izumi, S.-J. Yang, T. Uchiumi, Y. Iwamoto, M. Toi, T. Fujii, H. Yamana, H. Kinoshita, et al. The role of nuclear Y-box binding protein 1 as a global marker in drug resistance Mol. Cancer Ther., November 1, 2004; 3(11): 1485 - 1492. [Abstract] [Full Text] [PDF]

				P. S. Holm, H. Lage, S. Bergmann, K. Jurchott, G. Glockzin, A. Bernshausen, K. Mantwill, A. Ladhoff, A. Wichert, J. S. Mymryk, et al. Multidrug-resistant Cancer Cells Facilitate E1-independent Adenoviral Replication: Impact for Cancer Gene Therapy Cancer Res., January 1, 2004; 64(1): 322 - 328. [Abstract] [Full Text] [PDF]

				M. Tanabe, H. Izumi, T. Ise, S. Higuchi, T. Yamori, K. Yasumoto, and K. Kohno Activating Transcription Factor 4 Increases the Cisplatin Resistance of Human Cancer Cell Lines Cancer Res., December 15, 2003; 63(24): 8592 - 8595. [Abstract] [Full Text] [PDF]

				H. Uramoto, H. Izumi, T. Ise, M. Tada, T. Uchiumi, M. Kuwano, K. Yasumoto, K. Funa, and K. Kohno p73 Interacts with c-Myc to Regulate Y-box-binding Protein-1 Expression J. Biol. Chem., August 23, 2002; 277(35): 31694 - 31702. [Abstract] [Full Text] [PDF]

				H. C. Masuoka and T. M. Townes Targeted disruption of the activating transcription factor 4 gene results in severe fetal anemia in mice Blood, February 1, 2002; 99(3): 736 - 745. [Abstract] [Full Text] [PDF]

				C. H. He, P. Gong, B. Hu, D. Stewart, M. E. Choi, A. M. K. Choi, and J. Alam Identification of Activating Transcription Factor 4 (ATF4) as an Nrf2-interacting Protein. IMPLICATION FOR HEME OXYGENASE-1 GENE REGULATION J. Biol. Chem., June 8, 2001; 276(24): 20858 - 20865. [Abstract] [Full Text] [PDF]